Gertsch Jürg
Department of Chemistry and Applied Biosciences, ETH Zürich, Wolfgang-Pauli-Str. 10, CH-8093 Zürich, Switzerland.
J Ethnopharmacol. 2009 Mar 18;122(2):177-83. doi: 10.1016/j.jep.2009.01.010. Epub 2009 Jan 10.
This commentary is based on a general concern regarding the low level of self-criticism (-evaluation) in the interpretation of molecular pharmacological data published in ethnopharmacology-related journals. Reports on potentially new lead structures or pharmacological effects of medicinal plant extracts are mushrooming. At the same time, nonsense in bioassays is an increasing phenomenon in herbal medicine research. Only because a dataset is reproducible does not imply that it is meaningful. Currently, there are thousands of claims of pharmacological effects of medicinal plants and natural products. It is argued that claims to knowledge in ethnopharmacology, as in the exact sciences, should be rationally criticized if they have empirical content as it is the case with biochemical and pharmacological analyses. Here the major problem is the misemployment of the concentration-effect paradigm and the overinterpretation of data obtained in vitro. Given the almost exponential increase of scientific papers published it may be the moment to adapt to a falsificationist methodology.
本评论基于对民族药理学相关期刊上发表的分子药理学数据解读中自我批评(-评估)水平较低的普遍担忧。关于药用植物提取物潜在新先导结构或药理作用的报道如雨后春笋般涌现。与此同时,生物测定中的无意义现象在草药研究中日益增多。仅仅因为一个数据集是可重复的并不意味着它是有意义的。目前,有成千上万关于药用植物和天然产物药理作用的声称。有人认为,民族药理学中的知识声称,如同精确科学一样,如果具有经验内容,就像生化和药理分析那样,应该受到理性批判。这里的主要问题是浓度-效应范式的误用以及对体外获得的数据的过度解读。鉴于发表的科学论文几乎呈指数增长,或许是时候采用证伪主义方法了。